This is a community-generated profile. If you would like to claim it, please .
A new class of drugs to modulate the Human Microbiome
Vendanta Biosciences Funding
$0
22 rounds
Vendanta Biosciences has secured funding across 2 rounds and is valued at $0. Their most recent funding was raised on June 7, 2016.
Funding Rounds
U
$50000000
U
$50000000Investors of Vendanta Biosciences
Angel investor in biotech companies. Exits include Exos, Rifiniti, PIKA Energy, Poly6, Endra, Videolicious, Streamroot, QuadWrangle and doDoc
Invesco Asset Management
Rounds
U
U
PureTech Health is a biotech company dedicated to fighting diseases
Rounds
U
U
Rock Springs Capital
Rounds
U
U